Multimodal data integration in early-stage breast cancer

The use of biomarkers in breast cancer has significantly improved patient outcomes through targeted therapies, such as hormone therapy anti-Her2 therapy and CDK4/6 or PARP inhibitors. However, existing knowledge does not fully encompass the diverse nature of breast cancer, particularly in triple-neg...

Full description

Saved in:
Bibliographic Details
Main Authors: Arnau Llinas-Bertran, Maria Butjosa-Espín, Vittoria Barberi, Jose A. Seoane
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625000219
Tags: Add Tag
No Tags, Be the first to tag this record!